Perspective Therapeutics, Inc. — Director's Dealing 2017

Nov 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2017-11-20

Reporting Person: LAVOY THOMAS C (Director, CEO and Chairman of the Board)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-20	Common Stock	M	82810	$0.6050	Acquired	266333	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-20	Stock Options (right to buy)	$0.6050	M	82810	Disposed	2027-06-27	Common Stock (82810)	Direct

Footnotes

F1: 715,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested. The shares exercised on 11/20/2017 represent a portion of the shares that vested on 6/27/2017.